GLP-1 receptor agonists (GLP-1 RAs) are newer medications that were initially released as treatment for diabetes In higher doses, they have shown promising results in weight loss also Wegovy (semaglutide) was the first GLP-1 RA approved for weight loss by the FDA Zepbound (tirzepatide) was just recently approved by the FDA Early data shows better weight loss with Zepbound/tirzepatide than Wegovy/semaglutide What are GLP-1 receptor agonists and why do they work
doi:10.1080/14656566.2024.2356254
One important detail that catches people off guard: you cannot re-refrigerate tirzepatide after it has been stored at room temperature
This allows initial absorption before you lie down (reducing pillow transfer) while ensuring peak penetration aligns with early sleep when growth hormone release drives collagen synthesis
That said, individual tolerability varies, and dose escalation plans help reduce nausea and vomiting
Oakeshott JG, Johnson RM, Berenbaum MR, Ranson H, Cristino AS, Claudianos C